| HLAVÁČKOVÁ, Eva, Zdenka KŘENOVÁ, Petr BEJDÁK, Arpád KEREKES, Jaroslav ŠTĚRBA and Jiří LITZMAN. B cell lymphocyte subsets reconstitution and immunoglobulin levels dynamic after rituximab including treatment protocols of non-Hodgkin lymphoma in children and adolescents, one centrum experience (. B cell lymphocyte subsets reconstitution and immunoglobulin levels dynamic after rituximab including treatment protocols of non-Hodgkin lymphoma in children and adolescents, one centrum experience). In Multidisciplinary Symposium on the Immunological Consequences of Targeted Immune Therapies (ESID 2021). 2021. |
Other formats:
BibTeX
LaTeX
RIS
@proceedings{1790453,
author = {Hlaváčková, Eva and Křenová, Zdenka and Bejdák, Petr and Kerekes, Arpád and Štěrba, Jaroslav and Litzman, Jiří},
booktitle = {Multidisciplinary Symposium on the Immunological Consequences of Targeted Immune Therapies (ESID 2021)},
keywords = {B cell subsets rituximab NHL},
title = {B cell lymphocyte subsets reconstitution and immunoglobulin levels dynamic after rituximab including treatment protocols of non-Hodgkin lymphoma in children and adolescents, one centrum experience},
year = {2021}
}
TY - CONF
ID - 1790453
AU - Hlaváčková, Eva - Křenová, Zdenka - Bejdák, Petr - Kerekes, Arpád - Štěrba, Jaroslav - Litzman, Jiří
PY - 2021
TI - B cell lymphocyte subsets reconstitution and immunoglobulin levels dynamic after rituximab including treatment protocols of non-Hodgkin lymphoma in children and adolescents, one centrum experience
KW - B cell subsets rituximab NHL
ER -
HLAVÁČKOVÁ, Eva, Zdenka KŘENOVÁ, Petr BEJDÁK, Arpád KEREKES, Jaroslav ŠTĚRBA and Jiří LITZMAN. B cell lymphocyte subsets reconstitution and immunoglobulin levels dynamic after rituximab including treatment protocols of non-Hodgkin lymphoma in children and adolescents, one centrum experience (. B cell lymphocyte subsets reconstitution and immunoglobulin levels dynamic after rituximab including treatment protocols of non-Hodgkin lymphoma in children and adolescents, one centrum experience). In \textit{Multidisciplinary Symposium on the Immunological Consequences of Targeted Immune Therapies (ESID 2021)}. 2021.
|
